Knowledge Center

The Three Moves For Event Based Trading

Event Based Trading: A Daily Opportunity for Profit Event-based trading involves trading based on market events and announcements that can create movements in a stock price. Volatility tends to increase during these times, so traders have a better opportunity to generate higher trading profits. Even after the event occurs, residual volatility can remain for days […]

Read more...

Lockheed Martin Receives $320 Million Contract from US Missile Defense Agency

On August 6, Lockheed Martin (LMT) announced that the company received a  $320 million contract from the US Missile Defense Agency. Lockheed Martin will continue to evolve the Command, Control, Battle Management, and Communications (C2BMC) system that is part of the U.S. Ballistic Missile Defense System. Under this contract, Lockheed Martin will integrate the Long-Range […]

Read more...

July 2019 Scorecard

The July 2019 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide

Read more...

Neogen Corporation Awarded USDA Contract

Neogen Corporation (NEOG) announced on July 22 that they were awarded a contract with the U.S. Department of Agriculture (USDA). Under the terms of the contract, Neogen will provide dehydrated culture media to the USDA’s Food Safety and Inspection Service. The USDA uses the culture media to monitor raw and ready-to-eat meat and poultry products […]

Read more...

Vail Resorts Acquires Peak Resorts

On July 22, Vail Resorts, Inc. (MTN) announced that it reached an agreement to acquire Peak Resorts, Inc. (SKIS). Vail Resorts will pay $11 per share to purchase 100% of the outstanding shares in Peak Resorts. Vail Resorts will add 17 ski areas to its world-class networks through the acquisition.   Sonal issued an alert […]

Read more...

FDA Transfers BIVIGAM and Nabi-HB Licenses to ADMA Biologics

On July 8, ADMA Biologics, Inc. (ADMA) reported that they now hold the licenses for BIVIGAM and Nabi-HB that previously belonged to Biotest Pharamceuticals. This was the final regulatory item outstanding from ADMA’s acquisition of the Biotest Therapy Business Unit in June 2017. The FDA had to revoke the license from Biotest Pharmaceuticals and perform […]

Read more...

June 2019 Scorecard

The June 2019 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide

Read more...

Kratos Defense and Security Solutions Receives $4.1 Million Contract Award

On June 27, Kratos Defense and Security Solutions, Inc. (KTOS) announced that it received a $4.1 million contract award. The company will provide hardware and subsystems in support of a Command, Control, Communications, Computing, Combat and Intelligence, Surveillance and Reconnaissance (C5ISR) aerial defense related program. Customer and competitive security, however, prohibits Kratos from revealing more […]

Read more...

Extreme Networks Acquires Aerohive Networks

Extreme Networks (EXTR) announced on June 26 that the company entered into an agreement to acquire Aerohive Networks. Extreme Networks agreed to pay $4.45 per share in cash, for an approximate total price of $272 million. Aerohive Networks is a pioneer in cloud-managed networking.   Sonal issued an alert for subscribers at 6:30 am. Extreme […]

Read more...

Oceaneering International Awarded Contract by Andarko Mocambique Area 1

Oceaneering International, Inc. (OII) announced on June 18 that the company was awarded a contract from Andarko Mocambique Area 1. Oceaneering will supply umbilicals, distribution hardware, and aftermarket services under the terms of the contract. OII provides engineered services and products for the global offshore energy industry.   Sonal issued an alert about the event […]

Read more...

Krystal Biotech Reports Positive News from Phase 2 Clinical Trial of KB103

On June 24, Krystal Biotech (KRYS) reported positive news from its Phase 2 clinical trial of KB103. The treatment was effective and well tolerated by patients suffering from recessive dystrophic epidermolysis bullosa (RDEB). In addition, the FDA awarded Regenerative Medicine Advanced Therapy (RMAT) status to Krystal Biotech for KB103. Krystal Biotech is a gene therapy […]

Read more...